Publications:

Research Papers:

• Raghuram, N., Madhavi, Y., 1996. India's Declining Ranking: A scientometric study of Indian scientific output vis-a-vis world trends. Nature, 383, Oct 17, 572. doi:10.1038/383572a0, Impact Factor (IF): 28.417 in 1996 and 41.456 in 2015.
• Madhavi Y., 1997. Vaccine research: A case for National innovation Strategy. Current Science 73, 25-30. Impact Factor (IF): 0.376 in 1997 and 0.833 in 2015.
• Madhavi Y., 2003. The Manufacture of consent? Hepatitis B vaccination, A special article. Economic and Political Weekly (EPW) 38 (24), 2417-2424.
• Madhavi Y., 2005. Vaccine Policy in India. PLOS Medicine Weekly, May 2005, 2(5), e127, 0387-0391. Impact Factor (IF): 8.389 in 2005 and 15.25 in 2015.
• Madhavi Y., 2006. New combination vaccines: Backdoor entry into India’s Universal Immunization Programme? Current Science, 10 June, 90 (11), 1465-1469. Impact Factor (IF): 0.737 in 2006 and 0.833 in 2015.
•  Madhavi Y., 2007. Transnational factors and national linkages: Indian experience in Human Vaccines. Asian Biotechnology and Development Review (ABDR), 9(2), 1-43.
•  Puliyel J and Madhavi Y., 2008. Vaccines: Policy for Public good or private profit? Indian Journal of Medical Research, IJMR, 127, 1-3. PMID:18316845, Impact Factor (IF): 1.883 in 2008 and 1.666 in 2015.
• K.C. Garg, Suresh Kumar, Y. Madhavi, Mala Bahl, 2009. Bibliometrics of global malaria vaccine research, Health Information and Libraries Journal, Published online 18th Feb 2009, vol. 26 (1),2-31. Impact Factor (IF): 1.521 in 2009 and 0.89 in 2015.
• Madhavi, Y. 2009. Home-grown vaccines are crucial for Pubic Health. Opinion article, 23rd Sept 2009. http://www.scidev.net/en/health/opinions/home-grown-vaccines-are-crucial-for-public-health.html Madhavi Y. 2009. A Book Review on ‘The Vital Drop: Communication for Polio Eradication in India. Gitanjali Chaturvedi. Sage Publications India Pvt Ltd, new Delhi. Current Science, 10 July, 97 (1): 108. Impact Factor (IF): 0.782 in 2009 and 0.833 in 2015.
• Madhavi Y. 2009. Meeting local needs in global times: The Case of Universal vaccines in India, Journal of Health studies, Nov, vol 2, 81-105.
•  Dabade G., JSA., CSSM, SAMA, Madhavi Y et al., 2010. Concerns around Human Papilloma virus (HPV) Vaccine, Debate, Indian Journal of Medical Ethics (IJME), Jan - Mar 2010, Vol 7 (1): 38-41.
• Madhavi Y., Puliyel J.M., Mathew J.L, Raghuram, N., Phadke, A., Shiva, M., Srinivasan, S., Paul, Y., Srivastava, R.N., Parthasarathy, A., Gupta, S., Ranga, U., Vijayalakshmi V., Joshi, N., Nath, IGulhati, C.M., Chatterjee, P., Jain, A., Priya, R., Dasgupta, R., Sridhar, S., Dabade, D., Gopakumar, K.M., Abrol, D., Santhosh, M.R., Srivastava, S., Visalakshi, S., Bhargava A., Sarojini, N.B., Sehgal, D., Selvaraj, S., Banerji, D. (2010) Evidence-based national vaccine policy. Indian J Med Res 131, May 2010, pp 617-628. PMID:20516532, Impact Factor (IF): 1.826 in 2010 and 1.666 in 2015.
• Madhavi Y., and Raghuram. N, 2010. Crisis of speculation: Donors should fund only proven vaccine needs and local capacity-building, Rapid responses, British Medical Journal, May 17 2010. (www.bmj.com/cgi/eletters/340/may12_3/c2576).
• doi: http://dx.doi.org/10.1136/bmj.c2576 , Impact Factor (IF): 16.3 in 2010 and 17.445 in 2015.
•  Madhavi Y., and Raghuram. N, 2010. Pentavalent & other new combination vaccines: Solutions in search of problems, Indian J Med Res, October 2010, 132: 456-457. PMID:20966526, Impact Factor (IF): 1.826 in 2010 and 1.666 in 2015. Sarojini N B., Sandhya S., Madhavi Y., Srinivasan S., and Anjali S, 2010. The HPV Vaccine: Science, Ethics and Regulation, Economic & Political Weekly (EPW) Nov 27, 48: 27-34. Amit Sengupta, Anjali Shenoy, Sarojini N B and Madhavi.Y., Human Papilloma vaccine trials in India, The Lancet, Volume 377, Issue 9767, Page 719, 26 February 2011. (http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60270-5/fulltext)
• http://dx.doi.org/10.1016/S0140-6736(11)60270-5, Impact Factor (IF): 38.278 in 2011 and 39.06 in 2015
• Dabade G., JSA., CSSM, SAMA, Madhavi Y et al., 2010. Concerns around Human Papilloma virus (HPV) Vaccine, Debate, Indian Journal of Medical Ethics (IJME), Jan - Mar 2010, Vol 7 (1): 38-41.
• Madhavi Y., and Raghuram N. National vaccine policy in the era of vaccines seeking diseases and governments seeking public private partnerships, Current Science, Vol.102, NO. 4, 25 Feb 2012.p 57-58. Impact Factor (IF): 0.905 in 2006 and 0.833 in 2015.
•  Madhavi Y. vaccines and vaccine policy for universal healthcare. Social Change, June 2013 vol. 43 no. 2, 263-291.
•  Madhavi Y. (2014), An invited discussant Rapid response to an article titled ‘Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use’, by Tozzi AE. Vaccine. 2013, in pubmed commons. Published online In: http://www.ncbi.nlm.nih.gov/pubmed/24021304#cm24021304_2779
• Impact Factor (IF): 3.48
• Madhavi Y. (2014), An invited discussant in the first journal club discussion forum[https://brightoncollaboration.org/public/resources/forum/thread-list.html?forumId=daa4c392-fe61-49f6-b1e9-b4fba4ffc35f]. in response to an article on ‘ May 2014: Intussusception risk associated with rotavirus vaccines’ published online on 10th June 2014 titled ‘Risk assessment of intussusceptions with rotavirus vaccine in developing countries’. [file:///G:/all%20in%20one%20folder/madhvi/madhaviarticles/Thread%20view-intusseseption%20rota%20vaccine.htm]
•  Madhavi Y. (2015), In response to an invited discussant in journal club discussion forum from Brighton Collaboration on “Quadrivalent vaccination and risk of multiple sclerosis & other demyelinating diseases of the central nervous system” By Scheller et al., July 2015, JAMA, 313(1):54-61. My response published online [https://brightoncollaboration.org/public/resources/forum/thread-view.html?threadId=6b907512-bc3d-40e3-b999-f12d00261d45&page=1]
•  Madhavi Y. A response to an article on "Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India" in the website- pubpeers, a pubmed commons online discussion forum. The above comments are published at https://pubpeer.com/publications/481C3202AB9864F8BE9DD4457921D2?utm_source=Chrome&utm_medium=ChromeExtension&utm_campaign=Extensions

Books/Book chapters/Reports/Bulletins

•  Madhavi Y., 2010. Raghuram, N., Madhavi, Y., 1999. Are Indian Scientists losing in the World Publishing Race? In: Emerging Trends in Scientometrics and Informetrics, edited by P. S. Nagpaul, Allied publishers, New Delhi.
•  Madhavi Y., 2008. Indian Biopharmaceutical system and policies. In: Advances Biopharmaceutical Technology in India, Bioplan Associates Inc. Rockville, USA.
•  Liberalization: Its impact on Indian Vaccine S & T and Implications for National Vaccine Policy In : ‘Liberalizing Research in Science and Technology: Studies in Science Policy ‘// Edited by Nadia Asheulova, Binay Kumar Pattnaik, Eduard Kolchinsky, Gregory Sandstrom. Russian Academy of Sciences & IIT kanpur, Saint-Petersburg: Politechnika, 2010.

Technical Reports &Working Papers

• Madhavi Y., 1993. `New Drug policy 1992 and the growth of the drug industry.’ REP-134B/93, NISTADS. This is a part of project done during 4 months training on ‘Development policy and Planning’ in the Institute of Economic Growth, Delhi. 

•  Madhavi Y., 1995. ‘Linkages in vaccine biotechnology in India: Towards techno-economic networks in vaccine production’. WP-104/95, NISTADS, New Delhi. 

• Madhavi Y., 2001. Liberalization and the cost-benefit aspects of vaccines: the case of hepatitis B. Working paper series 1, CHS/WP/01/01. Mumbai: Centre for Health Studies, Tata Institute of Social Sciences, Mumbai, November, 1–44 (under Ford Foundation Fellowship).

• Madhavi. Y. 2008. Vaccine PSUs: Chronicle of an attenuation willfully caused. Medico Friends Circle Bulletin (MFC), 329, 1-7.

• Madhavi, Y., 2009. Human Vaccine science and technology status in India. In: India science and technology: 2008 Report, Editor, P Banerjee, National Institute of Science Technlogy and Development Studies, New Delhi (http://www.nistads.res.in/indiasnt2008/).

• Madhavi Y. Regulation of vaccine clinical trials in India, T3-133-136. In: India, science and technology: 2010-11 Report, Editor, P Banerjee, National Institute of Science Technology and Development Studies, New Delhi (http://www.nistads.res.in/indiasnt2010-11/index_India_S&T_2010-11.php)

• Y. Madhavi (2014), Healthcare Services and Capacity Development for Rural India under Globalization and Privatization, a chapter,  In: India: Science and Technology, Vol.3, edited by National Institute of Science, Technology and Development Studies (CSIR-NISTADS), Cambridge University Press, New Delhi, under Section  4 titled Rural India: S&T for Skills and Employment,  Dec 2014. Pages 69-74. 

• Y. Madhavi and Anubha Mahajan 2015, Affordable Healthcare: The Indian Perspective. A policy bulletin No.8, March 2015, published by NISTADs.

List of publications in newspapers/Magazines/ News letters

• Madhavi Y and Raghuram N., 1995. N. Drug Policy - 1994, I: Adding to the Citizens' Woes. The Hindu Businessline, Chennai, June 08.

• Madhavi Y and Raghuram N., 1995.  Drug Policy - 1994, II: Mortgaging Peoples' Health. The Hindu Businessline, chennai, June 09.

• Madhavi Y and Raghuram N., 1995. GATTing drugs; Not getting them. Down To Earth, April 30, 1995.

• Madhavi Y., 2000. Research & production in the Haffkine Institute: a century and beyond. Association for Consumers Action on Safety and Health (ACASH) News, Mumbai, July–Sept; 14 (3), 13–15.

• Madhavi Y, 2000. The issue of equity in primary vaccine technology development and its implications on the implementation of vaccine policy in India. Social Sciences and Health News Letter, 2 (1 & 2), Oct 2001, 5-17. 

Conferences/Seminars/Workshop

•  Raghuram, N., Madhavi, Y. And Mohanty, P. “Draft paper for a new technology policy (1993) – a critique”. Oral presentation at the symposium on ‘Science in India – pre and post independent era’, Sept 1994, Bose institute, Calcutta
•  Madhavi, Y and Raghuram, N. “Scientific Research and Social Realities in India – The case of radiation biology and the low dose radiation controversy”. Oral presentation at symposium on ‘Science in India – pre and post independent era’, Sept 1994, Bose institute, Calcutta.
•  Raghuram, N., Madhavi, Y. Are Indian Scientists losing in the World Publishing Race? Oral presentation at the seminar, Emerging Trends in Scientometrics and Informetrics, Feb 6-7, 1997, NISTADS, New Delhi. (General interest in S&T studies)
•  Madhavi, Y. “Transnational S&T Vs. Self Reliance: the Indian Experience in Vaccines” accepted for oral presentation in the International conference of the Society for Social Studies of Scienc on ‘Transnational meets Ethnoscience’, 23-26 Oct 1997, at Tucson, Arizona, USA.
•  Madhavi, Y. “Vaccine research and technology development in India”. Oral presentation at the workshop on Social Science and Immunization, Dec 5-6, 1997, Delhi School of Economics, New Delhi. (Part of ongoing project on vaccines, 1995-98)
•  Madhavi Y. ‘Science and public policy in developing country context: The case of vaccine research in India’, at the Salzburg Seminar on Scientific Development and the Democratic process, June 16-23, 1999 at Leopoldskron, Salzburg, Austria. (Participating as a Fellow of the Session 368).
•  Madhavi Y, ‘The Controversy around Hepatitis-B vaccine in Universal Immunization Programme. July 14th 2000, Centre for Health Studies, Tata Institute of Social Science, Mumbai.
•  Madhavi Y. `Globalization and Vaccines`. Oral presentation at the TISS & FOCUS on the Global South (India Programme) National Seminar `Structural Adjustment Policies and Social Sector`, 29 –31 Jan, 2001, Mumbai.
•  Madhavi Y. “Hepatitis B vaccination: international experience and Indian options”, seminar presentation, 25th June 2002, NISTADS, New Delhi.
•  Y. Madhavi. “Changing pharmaceutical R&D paradigm and the Emerging IPR regime: Implications for healthcare technologies”, participated as an invited discussant in an international conference on ‘Health care and food: The challenges of intellectual property, Biosafety and Bioethics,’ 1-5th Dec 2002, NISTADS New Delhi.
•  Madhavi Y. “Vaccines for India: Meeting local needs in global times”, International workshop on ‘The Global Vaccine System: Its Historical emergence and current vaccine dynamic’ 18th to 20th Oct 2006 at University of Amsterdam, Amsterdam. Participated as an invited team member from Prof. Stuart Bloom, university of Amsterdam for future international collaborative project along with UK, Europe and other developing countries.
•  Madhavi Y. and Dinesh Abrol. “The Place of R&D in Indian Pasteur Institutes: Understanding the Colonial Roots of Under-Development”. Third conference of the Asian Society for History of Medicine (ASHM) on “Health and Medicine in History: East-West Exchange,” 2-4 Nov 2006, School of Social Sciences-I, Jawaharlal Nehru University, New Delhi.
•  Madhavi Y. Human vaccines in India: Emerging International influences, 12th Oct 2007, Weekly seminar, School of International Studies, JNU, New Delhi.
•  Madhavi Y. “Human vaccines: Economic and Policy Issues” in a workshop on “Public Health Economics and Third World concerns in Health Security”, Dec 18th 2007 at Nistads, New Delhi.
•  Madhavi Y. “ Health & Economic Impacts of YSR’s Drug molecules”, in a Workshop on ‘Archives of the life and works of Dr Yellapragada SubbaRow’, 10th March 2008, National Institute of Nutrition, Hyderabad.
•  Madhavi Y. “ Vaccine choice & disease burden in economics of preventive health”, in a Workshop on ‘Health Economics’, 11th March 2008, National Institute of Nutrition, Hyderabad. Madhavi Y. “vaccines: The Magic Wand of Indian Public Health” World conference on Magic Bullets (Ehrlich II) 3rd -5th October 2008, Nürnberg, Germany.
•  Madhavi Y. “Indian Vaccine STS and Public Health”, Interaction with Science Students, 20th February 2009 Biochemistry Department, Daulat Ram College, Delhi University, Delhi.
•  Madhavi Y. “Indian Vaccine STS: Meeting local needs in Global Times”, ‘The Indian Republic at Crossroad’, 2nd Session of Indian Social Science Congress, 18th-21st December 2008, Department of Biotechnology, Jamia Milia Islamia, New Delhi.
•  Madhavi Y. “Liberalization: Its impact on Indian Vaccine S & T and Implications for National Vaccine Policy” International Conference on ‘LIBERALIZING RESEARCH IN SCIENCE & TECHNOLOGY- STUDIES IN SCIENCE POLICY’, 4th-6th February 2009, Centre for sociological and science-studies Research, Indian Institute of Technology Kanpur (IITK), Kanpur.
•  Madhavi Y. “Social Impact of Vaccine Policy” One day meeting on ‘Save Universal Immunization Programme’ 14th March 2009, L L A Building, Anna Salai, Chennai.
•  Madhavi Y. “ Access to vaccines: Governance, Regulation and policy” a workshop on ‘Universal Access and Rational Therapy’, India International Centre Annexe, New Delhi, 8-9th April 2009.
•  Madhavi Y. “Indian Vaccine R&D and innovation: Priorities & Realities” In: “ Status of the mandated actions under the GSPOA and Public Health, Innovation and Intellectual Property in India Workshop, 24-25 April 2009, National Health Systems Research Centre (NHSRC), National Institute of Health and Family Welfare (NIHFW) Campus, New Delhi.
•  Madhavi Y. “Demand-supply gaps in vaccines, status of indigenous production and policy” in a two day long brainstorming workshop on ‘ Sustainable National Vaccine policy’ 4-5th June 2009, NISTADS, New Delhi
•  Madhavi. Y. “vaccine economics and National Vaccine policy”, 23rd July 2009, Institute of Public Health, Public Health Foundation of India, Gurgaon.
•  Madhavi Y and N Raghuram. “Vaccines and Patient Safety in India”, In National Patient Safety conference, 12th October 2009, All Indian Institute of Medical Sciences, New Delhi.
•  Madhavi. Y. ‘New vaccines in National Immunization Programme: Dilemmas & debates’ 8th Dec 2009, Tuesday Seminar, NISTADS, New Delhi.
•  Madhavi.Y. Issues for evidence-based policy on combination vaccines in the context of pentavalent vaccine for Indian UIP , presented in expert committee meeting on pentavalent vaccine. 24th April, 2010. Indian Council of medical Research, New Delhi.
•  Madhavi Y. and N. Raghuram. ‘Emerging issues in Vaccine Policy’, Guha Research Conference, 21st Dec, 2010, Aurangabad.
•  Madhavi. Y. ‘New vaccine introduction in UIP: emerging issues in vaccine policy’, 18th Jan, 2011, Dellhi University, Delhi.
•  Madhavi. Y. “National/Global interfaces: ‘Fast, Slow or No’: Deciding to introduce the Pentavalent vaccine in India”, Invited Discussant on two day Indo-Norweign “SUM Medic Annual Workshop 2011: Explaining Differential Immunization Coverage” India International Centre, New Delhi, 17-18th Feb, 2011.
•  Madhavi. Y, ‘Evidence based national vaccine Policy: Agenda for Action. International Seminar on Innovation, Sustainability and Development, co-organised by CDS, Trivendrum, SPRU, UK and NISTADS, New Delhi, New Delhi, 28-30 June 2011.
•  Y. Madhavi. National vs. Global approaches to vaccine policy: The new face of an old conflict International Seminar Socio-economic and technological innovations in the globalizing world (STIGE-2011): Mechanism and Institutions NISTADS-Russian Academy of Sciences, 2-5 Nov 2011, NASC Complex, New Delhi.
•  Y. Madhavi and N. Raghuram. Vaccine PSUs & Rational Vaccine Policy: PIL in Supreme Court, SP Shukla & Ors Vs. Union of India, National Dialogue Using the Law for Public Health, Co-organised by Human Rights Law Network, LOCOST, PRAYAS & IHES, 17th –18th Dec 2011, Vishwa Yuvak Kendra, Chanakyapuri, New Delhi.
•  Madhavi. Y. ‘National Vaccine Policy: Evidence as the Key’. Seminar on Strengthening of Public Sector Health System for Universal access to Healthcare, 16-17 July 2012, India International Centre, New Delhi.
•  Madhavi. Y. “Health sector: Economics of vaccination policy.” An interactive lecture with graduate students in Economics Department in Miranda house, Delhi University on 19th Feb 2013 on its 3 day annual function named “The Last Verdict”.
•  Y. Madhavi, Invited discussant in a Round Table conference on ‘Governance of Regenerative Medicine and Patients' Needs in India’ 2nd July, 2014, IIC Annexe, organized by University of Sussex, RIS and Delhi University.
•  Y. Madhavi, Invited discussant in a multi-stakeholder discussion on ‘Facing Our Future: Countering Non-Communicable Diseases in India through Investments in Innovation’, 4th Aug 2014, Strategic Partners Group (SPAG Asia) New Delhi.
•  Y. Madhavi & Anubha Mahajan, ‘Access to affordable Healthcare in Post Liberalization in India’, 25th Nov 2014, CSIR-NISTADS, New Delhi.
•  Y. Madhavi, Invited consultant on ‘Consultations on potential biologics in enhancing healthcare outcomes and Barriers to access’, 13th Dec 2014, New Delhi.
•  Y. Madhavi, Invited participant in ‘Bridging the Gap: 4th Healthcare Leaders Forum (HLF)’ on March 12, 2015 at Hotel Royal Plaza, New Delhi.
•  Madhavi Y. (2015). Invited discussant on ‘Workshop on Clinical Trial Regulations of India,’ 2nd Dec, 2015, RIS, India Habitat Centre, New Delhi.
•  Y. Madhavi, “Preventive Medicine and Vaccination Policy”, National Workshop on “Law and Medicine” Organized by University School of Law & Legal Studies GGSIP University, New Delhi on 20th March, 2015.

 Organised Two Workshops

•  One day workshop was organized on ‘Health economics’ on 18th Dec 2007.
•  Two day brainstorming workshop on ‘Sustainable national Vaccine Policy’ in 4-5th June 2009. (Workshop output was a policy draft published in IJMR May 2010 for a wider national/international discussion)

 Awards/Honor

• Awarded senior visiting fellow under Ford foundation fellowship in Tata Institute of Social Sciences, Mumbai, during the period March-July 2000.
• Invited peer reviewer of ‘Cochrane (Acute respiratory Infection Group) review’ on combination vaccine.
• Invited peer reviewer for international Journal ‘Vaccine’. Reviewed 4 manuscripts
• Invited expert reviewer for the Journal ‘Science Communication’
• Invited expert reviewer of the Journal ‘World journal of Methodology’
• Invited expert reviewer of the journal ‘World journal of Medicine’
• Invited expert reviewer of the journal ‘Lancet’.
• Invited peer reviewer of a book chapter in an American based publication (Bioplan Associates, New York).
• Invited expert commentator to UNDP, Brazil on ‘Public sector role in accessing vaccines and medicines in developing countries’.
• Invited expert reviewer on the project proposal titled ‘Public health supply in Alberta’, Institute of Health Economic, Alberta, Canada.
• Invited peer reviewer on the project proposal titled ‘Explaining Differential Immunization Coverage; the case of pentavalent vaccine in India and Malawi’ University of Oslo, Norway. Invited reviewer of a project proposal on immunization coverage from Wellcome Trust, London.
• Provided expert inputs on access to vaccines as a single resource person from India to an international project on ‘the emerging generic medicines and vaccine sectors’ future role and the opportunities and barriers to supplying essential vaccines to those in developing countries’, on the request of project consultant from access to medicines foundation Netherlands and John Hopkins Bloomberg school of Public Health, International vaccine access centre.
• Invited expert to comment on ‘drug trials in India’ by China radio International, Beijing.

National

• discussant to a debate on ‘Ethics in conducting clinical trials of HPV vaccine in the districts of Andhra Pradesh’ with civil society and academia was published in Invited Referee of the Journal ‘Current Science’
• Invited peer reviewer of the journal ‘Indian Journal of Medical Research (IJMR)’
• An invited the Journal of Medical Ethics.
• Provided expert comments and inputs to an NGO on the project ‘Identification of Policy Concerns and Prioritizing Policy Research Questions in the area of Access to Medicines”.
• Invited expert on a committee on ‘Advisory group meeting on research on vaccine preventable diseases’ by ICMR, DHR.
• Invited expert on Advisory group meeting on research on pentavalent vaccine’ by ICMR, DHR.
• Under the heading  'Projects undertaken', please add the following.
• Linkages & Innovation Strategies in Vaccine R&D and Production in India (Principal investigator, in-house 1994-2004)
• Vaccine STS for Research and Policy’ (Principal investigator, In house 2005-2012)
• Modern biology research in India: An analysis (member, 2002-2003) The completed work was cited in (http://www.iornet.org/newiornet/sectoral/biotechnology/index.htm
• Global Strategy and Plan of Action on Public Health, Innovation & Intellectual Property (GSPOA) in India. (Sponsored, Member, 2011-2012)
• ‘Capacity building in vaccine R&D and innovation in India’ (in house)
• ‘Access to medicines in India under globalisation, liberalization and privatization’ (In house under Institutional Supra project).
• Healthcare Services and Capacity Development for Rural India under Globalization and Privatization (in house).
• ‘CSIR Healthcare: Technologies and their out-reach to the society’ under science Technology and Development Studies (STADS) (in house).

Designation Hierarchy

Senior Principal Scientist